Processa Pharmaceuticals Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include Takeda and Prolong Pharmaceuticals.
 Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Prolong Pharmaceuticals Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia. | ||
Founding Date | Founding Date 1990 | Founding Date 1781 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations South Plainfield, US HQ | |
Employees | Employees 61821% increase | Employees 47,4554% decrease | Employees 225% increase |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 43.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) ¥4.5t (FY, 2026) | Revenue (est.) N/A |
Net income | Net income ($164.1m) (FY, 2025) | Net income ¥192b (FY, 2026) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 57.8m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyProlong Pharmaceuticals
HQ
South Plainfield, US
Employees
22↑ 5% increase
Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia.
View company